- Home
- PNF vs EDAP Comparison
PNF vs EDAP Comparison
Compare PNF & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNF
- EDAP
- Stock Information
- Founded
- PNF 2001
- EDAP 1979
- Country
- PNF United States
- EDAP France
- Employees
- PNF N/A
- EDAP N/A
- Industry
- PNF Finance Companies
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PNF Finance
- EDAP Health Care
- Exchange
- PNF Nasdaq
- EDAP Nasdaq
- Market Cap
- PNF 54.9M
- EDAP 53.8M
- IPO Year
- PNF N/A
- EDAP 1997
- Fundamental
- Price
- PNF $6.89
- EDAP $1.49
- Analyst Decision
- PNF
- EDAP Buy
- Analyst Count
- PNF 0
- EDAP 3
- Target Price
- PNF N/A
- EDAP $8.50
- AVG Volume (30 Days)
- PNF 29.1K
- EDAP 37.1K
- Earning Date
- PNF 01-01-0001
- EDAP 08-27-2025
- Dividend Yield
- PNF 5.17%
- EDAP N/A
- EPS Growth
- PNF N/A
- EDAP N/A
- EPS
- PNF N/A
- EDAP N/A
- Revenue
- PNF N/A
- EDAP $67,840,467.00
- Revenue This Year
- PNF N/A
- EDAP N/A
- Revenue Next Year
- PNF N/A
- EDAP N/A
- P/E Ratio
- PNF N/A
- EDAP N/A
- Revenue Growth
- PNF N/A
- EDAP 3.69
- 52 Week Low
- PNF $6.37
- EDAP $1.26
- 52 Week High
- PNF $9.06
- EDAP $5.27
- Technical
- Relative Strength Index (RSI)
- PNF 49.11
- EDAP 32.18
- Support Level
- PNF $6.90
- EDAP $1.46
- Resistance Level
- PNF $7.04
- EDAP $1.63
- Average True Range (ATR)
- PNF 0.06
- EDAP 0.10
- MACD
- PNF -0.00
- EDAP -0.01
- Stochastic Oscillator
- PNF 36.84
- EDAP 5.88
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.